CytoSorbents Corporation (CTSO)

[Lakersrback]

I'm not too worried about the new player. I think the beads unique quality to remove based on size sets us apart. The only real advancers in the space would be AEMD and EDTXF. Both, and in particular EDTXF have made the most FDA advancement. EDTXF is closing in on approval as they are running their phase 3B confirmatory trial at now 13 US sites. The addition of Dr. John Kellum as EDTXF's CMO is paying early dividends as he has just secured the Cleveland Clinic and U of Michigan as additional phase 3B sites. Important to remember EDTXF is going the distance with 28 day mortality as the primary endpoint and the FDA is allowing a 2 to 1 ratio of use in FAVOR of the EDTXF solution. I have bought more of this stock since Kellum set up shop with the Canadian firm. I still love he beads and maintain a small position due to their unique ability to separate by size. The beads are very likely the cutting edge when it comes to filtration. ALL just my humble thoughts!!!!!!!! EDTXF trades very little and is HEAVILY insider owned, perhaps the most tightly owned 244 million shares I have ever witnessed...does this mean anything?? hard to know?